Zealand Pharma (Denmark) Story
| ZEAL Stock | DKK 626.00 15.00 2.45% |
About 55% of Zealand Pharma's investors are presently thinking to get in. The analysis of current outlook of investing in Zealand Pharma AS suggests that some traders are interested regarding Zealand Pharma's prospects. Zealand Pharma's investor sentiment overview provides quick insight into current market opportunities from investing in Zealand Pharma AS. The current market sentiment, together with Zealand Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Zealand Pharma AS stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Zealand Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Zealand daily returns and investor perception about the current price of Zealand Pharma AS as well as its diversification or hedging effects on your existing portfolios.
Zealand |
Requested story not found. it has been either deleted or moved. View all stories for Zealand Pharma AS.
Zealand Pharma Latest Timeline
Zealand Pharma AS is currently traded for 626.00on Copenhagen Exchange of Denmark. About 56.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.31. Zealand Pharma AS recorded a loss per share of 23.13. The entity had not issued any dividends in recent years.Check out Zealand Pharma Hype Analysis, Zealand Pharma Correlation and Zealand Pharma Performance. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Zealand Stock analysis
When running Zealand Pharma's price analysis, check to measure Zealand Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zealand Pharma is operating at the current time. Most of Zealand Pharma's value examination focuses on studying past and present price action to predict the probability of Zealand Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zealand Pharma's price. Additionally, you may evaluate how the addition of Zealand Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |